Blood Test Accurately Predicts Five-Year Alzheimer’s Risk​

The analysis reveals that asymptomatic individuals presenting with very high baseline p-tau217 concentrations face an absolute 38% risk of developing cognitive impairment within 5 years, escalating to 78% within 10 years.​